Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studyJoshua J. Solomon, Marilyn K. Glassberg, Ian Forrest et al.|The Lancet Respiratory Medicine|2022Cited by 211
Autologous Adoptive T-cell Therapy for Recurrent or Drug-resistant Cytomegalovirus Complications in Solid Organ Transplant Recipients: A Single-arm Open-label Phase I Clinical TrialCorey Smith, Rajiv Khanna, Leone Beagley et al.|Clinical Infectious Diseases|2018Cited by 105
Adoptive T‐cell immunotherapy for ganciclovir‐resistant CMV disease after lung transplantationChien‐Li Holmes‐Liew, Rajiv Khanna, Mark Holmes et al.|Clinical & Translational Immunology|2015Cited by 70
T cell repertoire remodeling following post-transplant T cell therapy coincides with clinical responseCorey Smith, Rajiv Khanna, Dillon Corvino et al.|Journal of Clinical Investigation|2019Cited by 24
Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patientsVijayendra Dasari, Rajiv Khanna, Andrea Schuessler et al.|Molecular Therapy — Methods & Clinical Development|2016Cited by 18